An early warning sign from Community Living

By Pepper Parr

November 16th, 2022



See what is set out in the piece below as one of those early warning signs.

We are still in the midst of a pandemic and we have to deal with that fact.

Community Living, an agency that is committed to meaningful inclusion in our community of people who have a developmental disability, reports that they are currently experiencing a challenging respiratory illness season. There are several viruses circulating in our community including COVID-19, respiratory syncytial virus (RSV) and influenza. We are seeing an increase in illness from RSV compared to previous years and influenza season began a month earlier than expected.

The healthcare system is reporting an increase in severity of illness from these viruses. We are also seeing a huge spike in COVID-19 cases for our employees and the people we support.
As we have done for over 2.5 years, we will continue to use all layers of protection to keep all stakeholders safe.

These layers include:

: Masking at all times
: Daily screening
: Rapid antigen testing of employees 3 times a week
: 10 day isolation when someone (staff or person supported tests positive)

The flu vaccine is designed to protect against strains of the influenza virus that are circulating during influenza season. The vaccine stimulates the body’s immune system to build antibodies against influenza, making it stronger and ready to fight off the illness before it starts. This year’s vaccine appears to be a good match to the circulating strain of the virus. Everyone can receive the flu vaccine at no cost by booking an appointment at their doctor’s office, or a local pharmacy, or a walk-in clinic.

Children under 2 years of age must visit their doctor to receive the flu vaccine. Flu vaccines do not provide protection against COVID-19 virus.

COVID-19 Vaccines: Bivalent vaccines are readily available and we strongly recommend that everyone gets this extra blanket of protection.

Return to the Front page
Print Friendly, PDF & Email

Comments are closed.